Allergan's (AGN) Tobira (TBRA) Deal Highlights Intercept (ICPT) and NASH Opportunity - Baird
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Biotech Investors Look for Next Jackpot After Tobira (TBRA) Acquired at up to a 1650% Premium
September 20, 2016 10:20 AM EDTBiotech investors are used to wild swings in stocks they own but even the stomach-hardened group were aflutter this morning after Allergan (NYSE: AGN) continued its post generic-sale buying spree by acquiring tiny NASH company Tobira Therapeutics (NASDAQ: TBRA) for up to a 1650% premium.
Closing a $4.74 per share on Monday, Allergan agreed to acquire... More
NASH Stocks on Watch after Allergan Acquires Tobira at Massive Premium
September 20, 2016 8:12 AM EDTA number of NASH stock are seeing upside after Allergan plc (NYSE: AGN) agreed to acquire Tobira Therapeutics, Inc. (NASDAQ: TBRA) for an upfront payment of $28.35 per share, in cash, and up to $49.84 per share in Contingent Value Rights (CVRs).... More